Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06181149 · ClinicalTrials.gov registry record · NA

Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter

A NA study of Healthy Subjects and Stuttering, Developmental, sponsored by Arizona State University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT06181149: Recruiting NA study of Healthy Subjects and Stuttering, Developmental, sponsored by Arizona State University.

NCT06181149 is a NA study of Healthy Subjects and Stuttering, Developmental that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 300 participants, above the 124-participant average among 69 other Healthy Subjects trials with a reported enrollment target (142% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06181149, a NA study of Healthy Subjects and Stuttering, Developmental, is actively recruiting participants, sponsored by Arizona State University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

Stuttering negatively impacts communication and reduces the overall quality of life and well-being of individuals who stutter. This study will provide a strong foundation for developing neural and behavioral interventions for stuttering. Participants will be asked to name pictures, read words/sentences silently or aloud, and listen to speech and nonspeech sounds while their speech, muscle, and brain signals are collected. Some participants may also receive brain stimulation while reading and speaking.

Primary Outcome

Participants will hear speech sounds in each trial before speaking or reading words. Participants' brain activity will be recorded while completing the speaking or reading tasks. The investigators will measure how the participant's brain activity in response to the played sounds changes during speaking and reading tasks. For this purpose, the investigators will measure the amplitude of the brain activity (in microvolts; µV) measured using a commercial electroencephalography system. The amplitude

Interventions

  • BEHAVIORAL Delaying speech initiation
  • BEHAVIORAL Auditory errors and pre-speech auditory modulation
  • BEHAVIORAL Contributions of the speech premotor cortex to pre-speech auditory modulation
  • BEHAVIORAL Delaying auditory feedback

Study Locations (2)

Arizona

  • Arizona State University - Tempe

Washington

  • Univeristy of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-01-01
Est. Completion 2027-12-30
Phase NA
Arizona State University

187 total trials

What NCT06181149 shows while recruiting

NCT06181149 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 124-participant average among 69 other Healthy Subjects trials with a reported enrollment target (142% higher).

The record links to 2 conditions, with Healthy Subjects appearing as the primary indexed condition, and to 4 interventions - of which Delaying speech initiation is the first listed.

NCT06181149 reports a single indexed study location in Arizona, Washington.

Frequently Asked Questions

What is clinical trial NCT06181149 about?

NCT06181149 is a clinical study titled "Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter". Stuttering negatively impacts communication and reduces the overall quality of life and well-being of individuals who stutter. This study will provide a strong foundation for developing neural and behavioral interventions for stuttering. Participants will be asked to name pictures, read words/senten...

What is the current status of trial NCT06181149?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-01-01. Estimated completion is 2027-12-30.

What conditions does trial NCT06181149 study?

This clinical trial studies the following conditions: Healthy Subjects, Stuttering, Developmental.

What interventions are being tested in trial NCT06181149?

The interventions under investigation include: Delaying speech initiation (BEHAVIORAL), Auditory errors and pre-speech auditory modulation (BEHAVIORAL), Contributions of the speech premotor cortex to pre-speech auditory modulation (BEHAVIORAL), Delaying auditory feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06181149?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06181149 being conducted?

This trial has 2 study locations across Arizona, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subjects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06181149's enrollment target sits among peer trials

300 5th of 69 higher than 65 of 69 other Healthy Subjects trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06181149, the US trial registry maintained by the National Library of Medicine. NCT06181149 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.